Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for R Vijayalakshmi Intimation of change in name of registry activity of the Company's Registrar and Share Transfer Agent
Orchid Pharma Ltd has informed BSE regarding "Intimation of change in name of registry activity of the Company's Registrar and Share Transfer Agent". Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for K Raghavendra Rao Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for K Raghavendra Rao Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for K Raghavendra Rao & R Vijayalakshmi Results Press Release for December 31, 2016
Orchid Pharma Ltd has informed BSE about : 1. Result Press Release for the period ended December 31, 2016 Standalone Financial Results, Limited Review Report for December 31, 2016
Orchid Pharma Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Standalone Limited Review for the period ended December 31, 2016 Board Meeting Intimation for Results & Closure of Trading Window
Orchid Pharma Ltd has informed BSE that a meeting of the Board of Directors is proposed to be held on February 07, 2017, to approve the unaudited financial results of the Company for the period from October 01, 2016 to December 31, 2016.Also, the trading window for dealing in the securities of the Company shall remain closed for all the insiders from January 30, 2017 to February 09, 2017 (both days inclusive). Shareholding for the Period Ended December 31, 2016
Orchid Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Orchid Pharma Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.